沪指重返3600点关口 创新药板块持续升温

Market Overview - The A-share market exhibited a strong oscillation pattern, with the Shanghai Composite Index surpassing the 3600-point mark, closing at 3609.71 points, up 0.33% [2] - The total trading volume in the Shanghai and Shenzhen markets reached 180.32 billion yuan, an increase of over 60 billion yuan compared to the previous day [2] Pharmaceutical Sector Performance - The pharmaceutical and biotechnology sector led the market, with the Shenwan Pharmaceutical and Biotechnology Index closing up 2.06%, driven by significant gains in innovative drugs and CROs [3] - Notable stocks such as Ruizhi Pharmaceutical, Aoxiang Pharmaceutical, and Jiuzhou Pharmaceutical hit the daily limit, while leading innovative drug company Heng Rui Pharmaceutical rose nearly 3% after a previous limit-up [3] - Heng Rui Pharmaceutical announced a collaboration with GSK, granting exclusive rights for the HRS-9821 project and up to 11 additional projects, with a potential total transaction value of approximately 12 billion USD [3] - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of the year, a year-on-year increase of 101.92%, and plans to distribute a cash dividend of 3.5 yuan per 10 shares [3] AI Hardware Sector Dynamics - The AI computing hardware sector showed strong momentum, with the PCB concept experiencing a surge, and the CPO concept seeing multiple stocks reach new highs [5] - CPO leader Zhongji Xuchuang rose by 9.41%, achieving a historical high, with a year-to-date increase of approximately 70% [5] - According to Guojin Securities, CPO technology significantly reduces power consumption by 30% to 50% while enhancing data transmission speed and bandwidth density, which is crucial for supporting large model iterations [5] Market Sentiment and Future Outlook - The A-share market is expected to continue its upward trend, driven by favorable funding conditions and policy expectations [6] - Recent data indicates an increase in public and retail investor participation, with the balance of margin trading nearing 2 trillion yuan, reflecting a strong willingness to enter the market [6] - Guotai Junan Securities anticipates that the funding environment will support further market growth, particularly in large financial assets [7]